Showing 374 results

Filters Content type: News, Editors' picks Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

Resistance

Transmitted Drug Resistance to Tenofovir and Emtricitabine is declining in China

Editor's pick
Infectious Disease Advisor
12 August 2021
PrEP science

Two PrEP medications are now available. Equally safe/effective. The biggest difference? The price tag.

Editor's pick
Medical Xpress
5 August 2021
Coronavirus

PrEP Study Sees No Link Between Tenofovir and COVID-19

Editor's pick
POZ
28 July 2021
Antibody-based prevention

HIV vaccines and immunotherapies “would be further along” if they had the resources of COVID-19, says leading antibody researcher

News
28 July 2021
Transgender people

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

News
22 July 2021
Injectable & long-acting PrEP

Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women

News
22 July 2021
Transgender people

How can HIV research better align with the realities of transgender and gender-diverse people?

News
22 July 2021
Injectable & long-acting PrEP

IAS: Merck's long-acting HIV med hits protective levels in phase 2

Editor's pick
FierceBiotech
21 July 2021
PrEP science

PrEP failures in African programmes are rare, but some are happening in people with good adherence

News
21 July 2021
PrEP

PrEP for women in Europe webinar: Part 2

News
5 July 2021
PrEP science

Continuing declines in HIV diagnoses thanks to successful PrEP roll-out in New South Wales

Editor's pick
University of New South Wales
2 July 2021
PrEP

PrEP for women in Europe webinar: Part 1

News
10 June 2021
PrEP science

Users of event-driven PrEP take it when needed, Dutch study finds

News
25 May 2021
HIV prevention policy

The future of antibody-based HIV prevention

Editor's pick
IAVI
10 May 2021
PrEP science

As CROI 2021 Attests, the PrEP Revolution Is Coming

Editor's pick
TheBodyPro
6 April 2021
Injectable & long-acting HIV treatment

Top 5 stories on injectable HIV treatment and prevention from CROI 2021

News
23 March 2021
PrEP science

Low New-HIV Rate With Both Daily and On-Demand PrEP in Paris MSM

Editor's pick
NATAP
17 March 2021
Drug interactions & pharmacokinetics

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

News
16 March 2021
PrEP science

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

News
10 March 2021
Sexually transmitted infections prevention

Antibiotics to prevent STIs – for or against?

News
10 February 2021
PrEP science

A pill, a ring or a jab: The future of HIV prevention is choice

Editor's pick
Bhekisisa
4 February 2021
Vaginal rings & topical PrEP

Biodegradable TAF Implants Protect 6 of 6 Macaques From Vaginal SHIV

Editor's pick
NATAP
2 February 2021
Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

News
27 January 2021
PrEP programmes & uptake

Huge fall in new HIV infections after roll-out of PrEP in Scotland

News
21 January 2021